大凌集团(00211.HK)拟5供1发行红利认股权证认购价折让82%
格隆汇7月29日丨大凌集团(00211.HK)公布,董事会建议,按於记录日期每持有5股股份获发1份认股权证的基准向合资格股东发行红利认股权证。全面行使该10.66亿份认股权证所附认购权将导致发行10.66亿股新股份,占经扩大后已发行股本约16.67%。初步认购价0.01港元,较7月26日收市价股0.056港元折让约82%。
根据每股新股份初步认购价0.01港元,公司将收取认购款项总额约1066万港元。董事相信,发行红利认股权证将为股东提供参与公司发展之机会。倘认股权证所附认购权获行使,发行红利认股权证亦将加强公司股本基础及增加公司营运资金。公司拟将认购权获行使时收取任何认购款项拨作集团的一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.